Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

718
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
718
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

588
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
588
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term efficacy and safety of dupilumab in patients enrolled from Latin American centers from the open-label extension LIBERTY ASTHMA TRAVERSE study.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Cerebral and bone multidrug resistant tuberculosis treated with the BPaLM regimen: case report.

Frontiers in pharmacology·2026
Same author

Biomarker tests of progression from tuberculosis infection to disease: a systematic review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Tuberculosis in children and young people in a low-incidence country: Shifting trends and the urgent need for targeted vaccination in those at risk.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Cefiderocol as a Successful Therapy for Osteomyelitis Due to XDR <i>Pseudomonas aeruginosa</i>: A Case Report and Literature Review.

Antibiotics (Basel, Switzerland)·2025
Same author

Accuracy of the Phenotypic 1G Test to Detect Mycobacterium tuberculosis and Drug Resistance From Sputa in the US-Mexico Border.

The Journal of infectious diseases·2025
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Breaking the barriers: Migrants and tuberculosis.

Giovanni Sotgiu1, Masoud Dara2, Rosella Centis3

  • 1University of Sassari, Department of Biomedical Sciences, Clinical Epidemiology and Medical Statistics Unit, Sassari, Italy.

Presse Medicale (Paris, France : 1983)
|March 4, 2017
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) poses a significant public health challenge globally, exacerbated by drug resistance and co-infection with HIV/AIDS. Migrant populations from high-incidence areas present new epidemiological concerns, requiring improved detection and management strategies.

More Related Videos

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.3K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K

Related Experiment Videos

Last Updated: Mar 6, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.3K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Tuberculosis (TB) remains a critical global health issue, particularly in low- and middle-income countries, complicated by drug resistance and HIV/AIDS co-infection.
  • High-income countries face potential resurgences of TB due to socio-economic factors and challenges in healthcare systems.
  • Migrant populations from high TB incidence regions introduce complex epidemiological challenges in regions with unprepared healthcare infrastructures.

Purpose of the Study:

  • To highlight the growing concern of tuberculosis transmission among migrant populations.
  • To underscore the limitations in current diagnostic tools and healthcare policies for latent TB infection and active TB disease.
  • To advocate for enhanced political commitment and targeted strategies for TB control in the context of migration.

Main Methods:

  • This study is a review and analysis of current public health challenges and policies related to tuberculosis.
  • It synthesizes scientific evidence regarding the detection and management of TB in diverse healthcare settings.
  • The analysis considers the impact of migration on TB epidemiology and healthcare systems in Europe, specifically within EU countries.

Main Results:

  • Existing healthcare management for latent TB infection and active TB disease is heterogeneous across Europe, with varying policies.
  • There is a lack of robust scientific evidence for early and efficient TB case detection.
  • Diagnostic tools for latent TB infection lack adequate accuracy, and challenging conditions in migrant centers increase transmission risk.

Conclusions:

  • Current migration trends pose significant human and healthcare threats, necessitating urgent advocacy and political commitment.
  • There is a critical need for new, homogeneous, and targeted policies and strategies to manage TB effectively.
  • Improving the health of both migrant and autochthonous populations requires a coordinated and evidence-based approach to TB control.